Oliva Mejía-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oliva Mejía-Rodríguez has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Citlalli Orizaga de la Cruz
Hospital General Regional N.(o) 1 IMSS, Morelia, Michoacán, México
4 shared publicationsMartha Eva Viveros Sandoval
4 shared publicationsSergio Gutiérrez Castellanos
Hospital General Regional N.(o) 1 IMSS, Morelia, Michoacán, México; Facultad de Ciencias Médicas y Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
4 shared publicationsCleto Alvarez-Aguilar
Hospital General Regional No 1. (IMSS), Morelia, Mich, Mexico
3 shared publicationsVenice Chávez Valencia
3 shared publications- Bengt Lindholm
Renal Medicine, Karolinska Institutet, M99 Karolinska University Hospital Huddinge, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
Low-Protein Diet Supplemented with Ketoanalogues and Progression of Chronic Kidney Disease in Diabetic Patients: A Multicenter Randomized Controlled Trial
Background/Objectives: Low-protein diets (LPD) and very-low-protein diets supplemented with Ketoanalogues (sVLPD) delay initiation of dialysis in non-diabetic patients with chronic kidney disease (CKD). sVLPD is not recommended in patients with type 2 diabetes mellitus (T2DM), and information about LPD supplemented with Ketoanalogues (LPD + KA) is scarce or inconclusive. The objective of this study is to provide further evidence on the benefits and safety of LPD supplemented with KA (LPD + KA) compared with LPD alone in reducing CKD progression in patients with T2DM. Methods: T2DM patients in stages 3b-4 of CKD (n = 149) were included in a multicenter, randomized, controlled trial and received LPD + KA or LPD, 1 year follow-up. Evaluations were carried out bimonthly. In both groups, protein intake was 0.6 g/kg/day, and the LPD + KA group received KA at the recommended dose. The primary outcome was a decline in eGFR, calculated with Creatinine and with Cystatin C. Secondary outcomes were dialysis requirement, deterioration in nutritional status, hospitalization, morbidity, and mortality. Results: During follow-up, protein nitrogen appearance was 0.556 ± 0.119 and 0.576 ± 0.134 g/kg/day in LPD + KA and LPD, respectively (p = 0.002). The decrease in eGFRCysC from the baseline was −4.29 ± 0.96 mL/min in LPD + KA and −8.54 ± 2.19 mL/min in LPD (using linear mixed-effects model, p = 0.012). eGFRCr did not show differences. There were no differences in nutrition status, metabolic control, adverse events, hospitalizations, or hospital days. Conclusions: Ketoanalogues slow the decline in eGFRCyC but not eGFRCr in T2DM patients, even without differences in protein intake. LPD + KA may be considered useful and safe; however, due to limitations in sample size and follow-up, as well as observed changes in Cr metabolism, the results warrant confirmation with a more robust design and a longer follow-up period.
Open AccessLow-Protein Diet Supplemented with Ketoanalogues and Progression of Chronic Kidney Disease in Diabetic Patients: A Multicenter Randomized Controlled Trial
Background/Objectives: Low-protein diets (LPD) and very-low-protein diets supplemented with Ketoanalogues (sVLPD) delay initiation of dialysis in non-diabetic patients with chronic kidney disease (CKD). sVLPD is not recommended in patients with type 2 diabetes mellitus (T2DM), and information about LPD supplemented with Ketoanalogues (LPD + KA) is scarce or inconclusive. The objective of this study is to provide further evidence on the benefits and safety of LPD supplemented with KA (LPD + KA) compared with LPD alone in reducing CKD progression in patients with T2DM. Methods: T2DM patients in stages 3b-4 of CKD (n = 149) were included in a multicenter, randomized, controlled trial and received LPD + KA or LPD, 1 year follow-up. Evaluations were carried out bimonthly. In both groups, protein intake was 0.6 g/kg/day, and the LPD + KA group received KA at the recommended dose. The primary outcome was a decline in eGFR, calculated with Creatinine and with Cystatin C. Secondary outcomes were dialysis requirement, deterioration in nutritional status, hospitalization, morbidity, and mortality. Results: During follow-up, protein nitrogen appearance was 0.556 ± 0.119 and 0.576 ± 0.134 g/kg/day in LPD + KA and LPD, respectively (p = 0.002). The decrease in eGFRCysC from the baseline was −4.29 ± 0.96 mL/min in LPD + KA and −8.54 ± 2.19 mL/min in LPD (using linear mixed-effects model, p = 0.012). eGFRCr did not show differences. There were no differences in nutrition status, metabolic control, adverse events, hospitalizations, or hospital days. Conclusions: Ketoanalogues slow the decline in eGFRCyC but not eGFRCr in T2DM patients, even without differences in protein intake. LPD + KA may be considered useful and safe; however, due to limitations in sample size and follow-up, as well as observed changes in Cr metabolism, the results warrant confirmation with a more robust design and a longer follow-up period.
- Open Access
- 6 January 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 26
Short- and Middle-Term Nephroprotective and Cardioprotective Effects of Pentoxifylline in Patients with Diabetic Nephropathy: A Randomized Controlled Trial
Background/Objectives. Pentoxifylline (PTF) is an effective treatment to delay the progress of Diabetic Nephropathy; it also has beneficial effects on heart failure, two closely related clinical conditions. However, the simultaneous Nephroprotective and Cardioprotective effects of PTF have not been appropriately analyzed. The objective of this study was to analyze if both effects occur together in Diabetic patients. Material and Methods. A Randomized Controlled Trial was performed to compare Placebo (P-G) vs. PTF (400 mg/8 h) (PTF-G) in patients with CKD stages III–IV (KDIGO) due to Diabetic Nephropathy. Creatinine-Cystatin C-based Estimated Glomerular Filtration Rate (eGFRCysCCr) and Microalbuminuria were evaluated at baseline, six, and twelve months. Echocardiographic assessment of heart morphology and function was performed. Results. Ninety-three patients were available for the final analysis, 52 in the PTF group and 41 in the P group. There were no differences in clinical and biochemical parameters between groups at baseline. At 6 months, microalbuminuria changed 27.96 ± 43.06 in P-G and −30.27 ± 41.48 mg/24 h in PTF-G (p < 0.001), eGFRCysCCr changed −1.55 ± 7.10 in P-G and 1.40 ± 7.28 mL/min/1.73 m2 in PTF-G (p = 0.083), and left ventricular mass index (LVMI) changed 10.86 ± 16.40 in P-G and −2.71 ± 19.52 g/m2 in PTF-G (p = 0.001). At 12 months, microalbuminuria changed 24.10 ± 43.28 in P-G and −43.18 ± 52.13 mg/24 h in PTF-G (p < 0.001), eGFRCysCCr changed −6.55 ± 10.18 in P-G and 0.98 ± 8.17 mL/min/1.73 m2 in PTF-G (p = 0.008), and LVMI changed 20.79 ± 20.06 in P-G and −0.82 ± 25.95 g/m2 in PTF-G (p = 0.028). No significant adverse events occurred in any group. Conclusions. Pentoxifylline is a safe and effective treatment with combined Nephroprotective and Cardioprotective effects in advanced diabetic nephropathy.
- 6 January 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 26
Open AccessShort- and Middle-Term Nephroprotective and Cardioprotective Effects of Pentoxifylline in Patients with Diabetic Nephropathy: A Randomized Controlled Trial
Background/Objectives. Pentoxifylline (PTF) is an effective treatment to delay the progress of Diabetic Nephropathy; it also has beneficial effects on heart failure, two closely related clinical conditions. However, the simultaneous Nephroprotective and Cardioprotective effects of PTF have not been appropriately analyzed. The objective of this study was to analyze if both effects occur together in Diabetic patients. Material and Methods. A Randomized Controlled Trial was performed to compare Placebo (P-G) vs. PTF (400 mg/8 h) (PTF-G) in patients with CKD stages III–IV (KDIGO) due to Diabetic Nephropathy. Creatinine-Cystatin C-based Estimated Glomerular Filtration Rate (eGFRCysCCr) and Microalbuminuria were evaluated at baseline, six, and twelve months. Echocardiographic assessment of heart morphology and function was performed. Results. Ninety-three patients were available for the final analysis, 52 in the PTF group and 41 in the P group. There were no differences in clinical and biochemical parameters between groups at baseline. At 6 months, microalbuminuria changed 27.96 ± 43.06 in P-G and −30.27 ± 41.48 mg/24 h in PTF-G (p < 0.001), eGFRCysCCr changed −1.55 ± 7.10 in P-G and 1.40 ± 7.28 mL/min/1.73 m2 in PTF-G (p = 0.083), and left ventricular mass index (LVMI) changed 10.86 ± 16.40 in P-G and −2.71 ± 19.52 g/m2 in PTF-G (p = 0.001). At 12 months, microalbuminuria changed 24.10 ± 43.28 in P-G and −43.18 ± 52.13 mg/24 h in PTF-G (p < 0.001), eGFRCysCCr changed −6.55 ± 10.18 in P-G and 0.98 ± 8.17 mL/min/1.73 m2 in PTF-G (p = 0.008), and LVMI changed 20.79 ± 20.06 in P-G and −0.82 ± 25.95 g/m2 in PTF-G (p = 0.028). No significant adverse events occurred in any group. Conclusions. Pentoxifylline is a safe and effective treatment with combined Nephroprotective and Cardioprotective effects in advanced diabetic nephropathy.
- Open Access
- 2 August 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (8) , 786
Correlates of Theta and Gamma Activity during Visuospatial Incidental/Intentional Encoding and Retrieval Indicate Differences in Processing in Young and Elderly Healthy Participants
Incidental visuospatial learning acquired under incidental conditions is more vulnerable to aging than in the intentional case. The theta and gamma correlates of the coding and retrieval of episodic memory change during aging. Based on the vulnerability of incidental coding to aging, different theta and gamma correlates could occur under the incidental versus intentional coding and retrieval of visuospatial information. Theta and gamma EEG was recorded from the frontotemporal regions, and incidental/intentional visuospatial learning was evaluated in young (25–60 years old) and elderly (60–85 years old) participants. The EEG recorded during encoding and retrieval was compared between incidental low-demand, incidental high-demand, and intentional conditions through an ANCOVA considering the patient’s gender, IQ, and years of schooling as covariates. Older adults exhibited worse performances, especially in place–object associations. After the intentional study, older participants showed a further increase in false-positive errors. Higher power at the theta and gamma bands was observed for frontotemporal derivations in older participants for both encoding and retrieval. Under retrieval, only young participants had lower power in terms of errors compared with correct responses. In conclusion, the different patterns of power and coherence support incidental and intentional visuospatial encoding and retrieval in young and elderly individuals. The correlates of power with behavior are sensitive to age and performance.
- 2 August 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (8) , 786
Open AccessCorrelates of Theta and Gamma Activity during Visuospatial Incidental/Intentional Encoding and Retrieval Indicate Differences in Processing in Young and Elderly Healthy Participants
Incidental visuospatial learning acquired under incidental conditions is more vulnerable to aging than in the intentional case. The theta and gamma correlates of the coding and retrieval of episodic memory change during aging. Based on the vulnerability of incidental coding to aging, different theta and gamma correlates could occur under the incidental versus intentional coding and retrieval of visuospatial information. Theta and gamma EEG was recorded from the frontotemporal regions, and incidental/intentional visuospatial learning was evaluated in young (25–60 years old) and elderly (60–85 years old) participants. The EEG recorded during encoding and retrieval was compared between incidental low-demand, incidental high-demand, and intentional conditions through an ANCOVA considering the patient’s gender, IQ, and years of schooling as covariates. Older adults exhibited worse performances, especially in place–object associations. After the intentional study, older participants showed a further increase in false-positive errors. Higher power at the theta and gamma bands was observed for frontotemporal derivations in older participants for both encoding and retrieval. Under retrieval, only young participants had lower power in terms of errors compared with correct responses. In conclusion, the different patterns of power and coherence support incidental and intentional visuospatial encoding and retrieval in young and elderly individuals. The correlates of power with behavior are sensitive to age and performance.
- Open Access
- 12 May 2022
- Published by Elsevier in Learning and Instruction
- Vol. 80, 101629
Higher education students’ achievement emotions and their antecedents in e-learning amid COVID-19 pandemic: A multi-country survey
- 12 May 2022
- Published by Elsevier in Learning and Instruction
- Vol. 80, 101629
Open AccessHigher education students’ achievement emotions and their antecedents in e-learning amid COVID-19 pandemic: A multi-country survey
- Open Access
- 1 March 2022
- Vol. 60 (2) , 149-155
Conocimientos del programa PREVENIMSS en usuarios de una unidad de medicina familiar
Los programas PREVENIMSS son una estrategia para promover la salud en los tres niveles de prevención, con especial énfasis en el primer nivel de atención. Uno de sus objetivos es impactar en la morbimortalidad de enfermedades crónicas no transmisibles, como obesidad, diabetes e hipertensión, cuya prevención requiere de conocimientos para el autocuidado de la salud contenidos en estas guías. identificar la información que tienen los derechohabientes del IMSS sobre el autocuidado de la salud contenida en las guías PREVENIMSS. estudio descriptivo transversal. Previa firma de consentimiento informado se entrevistó a mil derechohabientes de una unidad de medicina familiar; 200 por cada grupo etario PREVENIMSS. Se formularon preguntas acerca de: 1. Promoción de la salud, 2. Prevención y control de enfermedades, 3. Detección de enfermedades, 4. Nutrición, 5. Salud sexual y reproductiva, y una pregunta abierta para identificar sus necesidades sobre el autocuidado de la salud. los encuestados respondieron tener conocimientos acerca de los componentes PREVENIMSS en: Promoción de la salud, el 62%; Nutrición, 43%; Prevención de enfermedades, 55.3%; Detección y control de enfermedades, 51.9%, y Salud sexual y reproductiva, 49.9%. El puntaje total obtenido por grupo etario fue: 0-9 años: 46.35 ± 14.36; 10-19 años: 46.02 ± 12.06; mujeres de 20 a 59 años: 46.79 ± 8.19, hombres de 20 a 59 años: 52.19 ±14.58, y adultos mayores de 60 años y más: 46.65 ± 13.34. la menor información se tiene en nutrición. El grupo de adolescentes fue el más afectado.
- 1 March 2022
- Vol. 60 (2) , 149-155
Open AccessConocimientos del programa PREVENIMSS en usuarios de una unidad de medicina familiar
Los programas PREVENIMSS son una estrategia para promover la salud en los tres niveles de prevención, con especial énfasis en el primer nivel de atención. Uno de sus objetivos es impactar en la morbimortalidad de enfermedades crónicas no transmisibles, como obesidad, diabetes e hipertensión, cuya prevención requiere de conocimientos para el autocuidado de la salud contenidos en estas guías. identificar la información que tienen los derechohabientes del IMSS sobre el autocuidado de la salud contenida en las guías PREVENIMSS. estudio descriptivo transversal. Previa firma de consentimiento informado se entrevistó a mil derechohabientes de una unidad de medicina familiar; 200 por cada grupo etario PREVENIMSS. Se formularon preguntas acerca de: 1. Promoción de la salud, 2. Prevención y control de enfermedades, 3. Detección de enfermedades, 4. Nutrición, 5. Salud sexual y reproductiva, y una pregunta abierta para identificar sus necesidades sobre el autocuidado de la salud. los encuestados respondieron tener conocimientos acerca de los componentes PREVENIMSS en: Promoción de la salud, el 62%; Nutrición, 43%; Prevención de enfermedades, 55.3%; Detección y control de enfermedades, 51.9%, y Salud sexual y reproductiva, 49.9%. El puntaje total obtenido por grupo etario fue: 0-9 años: 46.35 ± 14.36; 10-19 años: 46.02 ± 12.06; mujeres de 20 a 59 años: 46.79 ± 8.19, hombres de 20 a 59 años: 52.19 ±14.58, y adultos mayores de 60 años y más: 46.65 ± 13.34. la menor información se tiene en nutrición. El grupo de adolescentes fue el más afectado.
- Open Access
- 1 January 2018
- Published by Elsevier in Nefrología (English Edition)
- Vol. 38 (1) , 57-63
Prevalence of malnutrition-inflammation complex syndrome and its correlation with thyroid hormones in chronic haemodialysis patients
- 1 January 2018
- Published by Elsevier in Nefrología (English Edition)
- Vol. 38 (1) , 57-63
Open AccessPrevalence of malnutrition-inflammation complex syndrome and its correlation with thyroid hormones in chronic haemodialysis patients
- Open Access
- 1 January 2018
- Published by Elsevier in Nefrología
- Vol. 38 (1) , 57-63
Prevalencia del síndrome complejo de malnutrición e inflamación y su correlación con las hormonas tiroideas en pacientes en hemodiálisis crónica
- 1 January 2018
- Published by Elsevier in Nefrología
- Vol. 38 (1) , 57-63
Open AccessPrevalencia del síndrome complejo de malnutrición e inflamación y su correlación con las hormonas tiroideas en pacientes en hemodiálisis crónica
- 1 November 2017
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 11, S195-S200
Impact of a comprehensive intervention to families with teenage sons with overweight and obesity in a primary care setting: A case report
- 1 November 2017
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 11, S195-S200
Impact of a comprehensive intervention to families with teenage sons with overweight and obesity in a primary care setting: A case report
- Open Access
- 1 September 2017
- Published by Elsevier in Nefrología (English Edition)
- Vol. 37 (5) , 554-556
Inflammation in hemodialysis and their correlation with neutrophi-lymphocite ratio and platelet-lymphocyte ratio.
- 1 September 2017
- Published by Elsevier in Nefrología (English Edition)
- Vol. 37 (5) , 554-556
Open AccessInflammation in hemodialysis and their correlation with neutrophi-lymphocite ratio and platelet-lymphocyte ratio.
- Open Access
- 1 September 2017
- Published by Elsevier in Nefrología
- Vol. 37 (5) , 554-556
Inflamación en hemodiálisis y su correlación con los índices neutrófilos/linfocitos y plaquetas/linfocitos
- 1 September 2017
- Published by Elsevier in Nefrología
- Vol. 37 (5) , 554-556
Open AccessInflamación en hemodiálisis y su correlación con los índices neutrófilos/linfocitos y plaquetas/linfocitos